All In Biotech

Drug Trial Radar · NCT03833206

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients: Part I Dose Escalation

Last checked: Nov 20, 2026Latest source record: Apr 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

12

Planned (sponsor's estimate)

Start

Jan 15, 2027

Primary completion

Feb 28, 2028

Study completion Feb 28, 2028

Sponsor

Lead sponsor
BioLite, Inc.Industry
Sponsor type
Industry
Collaborators
American BriVision Corporation
First posted
Feb 6, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 21 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and the effective doses of PDC-1421 in cancer patients with depression.

Conditions

  • Major Depressive Disorder

Interventions

  • PDC-1421 CapsuleDrug

    PDC-1421 Capsule is a botanical investigational new drug containing the extract of Radix Polygalae (Polygala tenuifolia Willd.) as active ingredient.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Montgomery-Åsberg Depression Rating Scale (MADRS)Time frame: 5 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cedars-Sinai Health System

    Los Angeles, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.